By Cristina Roca

 

Bayer AG said Thursday that the U.S. Food and Drug Administration has approved its Mirena device for extended use as a contraceptive.

The German pharmaceutical and chemicals company said its supplemental new drug application for use of up to eight years in the contraception indication was approved by the regulator.

Mirena is a hormonal intrauterine system.

Its duration of use remains unchanged at up to five years for its second approved indication in the U.S.

 

Write to Cristina Roca at cristina.roca@wsj.com

 

(END) Dow Jones Newswires

August 18, 2022 09:03 ET (13:03 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Bayer (XE:BAYN)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Bayer Charts.
Bayer (XE:BAYN)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Bayer Charts.